Organotypic high-throughput screening identifies the combinatorial treatment of navitoclax and YM155 that target chemoresistant ovarian cancer cellsHilary A. Kenny,Carman Ip,Kasjusz Kordylewicz, Rachael Hoffmann, Sarah Rauch,Beatrice Malacrida,Frances R. Balkwill,Chiara Battistini,Ugo Cavallaro,Ernst LengyelCANCER RESEARCH(2024)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要